Castleview Partners, LLC Becton Dickinson & CO Transaction History

Castleview Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 17, 2022	SELL	$234.74 - $275.42 $54,694 - $64,172	-233 Reduced 31.53%	506 $124,000
Q2 2022 Aug 16, 2022	SELL	$234.74 - $275.42 $53,051 - $62,244	-226 Reduced 23.42%	739 $182,000
Q1 2022 May 16, 2022	SELL	$243.64 - $270.48 $48.7 Million - $54 Million	-199,716 Reduced 99.52%	965 $256,000
Q4 2021 Feb 17, 2022	BUY	$230.08 - $250.94 $46 Million - $50.2 Million	199,943 Added 27092.55%	200,681 $49.2 Million
Q2 2021 Aug 17, 2021	BUY	$232.65 - $254.58 $171,695 - $187,880	738 New	738 $179,000

1,737

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Castleview Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Castleview Partners, LLC with notifications on news.